Literature DB >> 9445477

Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B.

L Stephens1, K Anderson, D Stokoe, H Erdjument-Bromage, G F Painter, A B Holmes, P R Gaffney, C B Reese, F McCormick, P Tempst, J Coadwell, P T Hawkins.   

Abstract

Protein kinase B (PKB) is activated in response to phosphoinositide 3-kinases and their lipid products phosphatidylinositol 3,4, 5-trisphosphate [PtdIns(3,4,5)P3] and PtdIns(3,4)P2 in the signaling pathways used by a wide variety of growth factors, antigens, and inflammatory stimuli. PKB is a direct target of these lipids, but this regulation is complex. The lipids can bind to the pleckstrin homologous domain of PKB, causing its translocation to the membrane, and also enable upstream, Thr308-directed kinases to phosphorylate and activate PKB. Four isoforms of these PKB kinases were purified from sheep brain. They bound PtdIns(3,4,5)P3 and associated with lipid vesicles containing it. These kinases contain an NH2-terminal catalytic domain and a COOH-terminal pleckstrin homologous domain, and their heterologous expression augments receptor activation of PKB, which suggests they are the primary signal transducers that enable PtdIns(3,4,5)P3 or PtdIns- (3,4)P2 to activate PKB and hence to control signaling pathways regulating cell survival, glucose uptake, and glycogen metabolism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445477     DOI: 10.1126/science.279.5351.710

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  309 in total

1.  Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR.

Authors:  J Nakae; V Barr; D Accili
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

Review 2.  Multiple pathways control protein kinase C phosphorylation.

Authors:  D B Parekh; W Ziegler; P J Parker
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

Review 3.  Phosphatidylinositol 3' kinase signaling in mammary tumorigenesis.

Authors:  M P Scheid; J R Woodgett
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

4.  Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1.

Authors:  I Shin; A V Bakin; U Rodeck; A Brunet; C L Arteaga
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

Review 5.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

6.  Role of PI 3-kinase and PIP3 in submandibular gland branching morphogenesis.

Authors:  Melinda Larsen; Matthew P Hoffman; Takayoshi Sakai; Justin C Neibaur; Jonathan M Mitchell; Kenneth M Yamada
Journal:  Dev Biol       Date:  2003-03-01       Impact factor: 3.582

7.  alpha1B-Adrenergic receptor phosphorylation and desensitization induced by transforming growth factor-beta.

Authors:  M Teresa Romero-Avila; C Fabián Flores-Jasso; J Adolfo García-Sáinz
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

8.  Noncanonical activation of Akt/protein kinase B in {beta}-cells by the incretin hormone glucose-dependent insulinotropic polypeptide.

Authors:  Scott B Widenmaier; Arthur V Sampaio; T Michael Underhill; Christopher H S McIntosh
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

9.  Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B.

Authors:  Michael P Scheid; Paola A Marignani; James R Woodgett
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

10.  High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site.

Authors:  Ricardo M Biondi; David Komander; Christine C Thomas; Jose M Lizcano; Maria Deak; Dario R Alessi; Daan M F van Aalten
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.